Back

What have we learned from SGLT-2 Inhibitors in Heart Failure?

5 December 2020 (16:55 - 17:10)
Organised by:
Congress Presentation Part of: What have we learned from SGLT-2 inhibitors in heart failure? Other Open Access ESC Asia with APSC & AFC 2020

About the speaker

Photo
Professor Ricardo Fontes Carvalho

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

3 More presentations in this session

Presentation thumbnail
Welcome/Opening - What have we learned from SGLT-2 inhibitors in heart failure?
Professor S. Kang (Seoul, KR)
Video
Presentation thumbnail
Q&A - What have we learned from SGLT-2 inhibitors in heart failure?
Professor S. Kang (Seoul, KR) Professor R. Fontes Carvalho (Vila Nova de Gaia, PT)
Video
Presentation thumbnail
Closing/Conclusion - What have we learned from SGLT-2 inhibitors in heart failure?
Professor S. Kang (Seoul, KR)
Video

Access the full session

Session thumbnail
What have we learned from SGLT-2 inhibitors in heart failure?
Video

The Event

Event poster

ESC Asia with APSC & AFC 2020

5 December 2020 16:55 CET
You may be interested in
thumbnail
Webinar
SGLT2 inhibitors across the left ventricular function spectrum
24 September 2024
thumbnail
Congress Presentation
Investigation of biomarker response to SGLT2 Inhibition in heart failure (SiN-HF)
30 August 2025
thumbnail
Congress Session
The ESC Journal Family: focus on heart failure
26 August 2023
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources